Selegiline-induced	selegiline-induced	O	O
postural	postural	O	O
hypotension	hypotension	O	S_disease
in	in	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
:	:	O	O
a	a	O	O
longitudinal	longitudinal	O	O
study	study	O	O
on	on	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
drug	drug	O	O
withdrawal	withdrawal	O	O
.	.	O	O

OBJECTIVES	objectives	O	O
:	:	O	O
The	the	O	O
United	united	O	O
Kingdom	kingdom	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
Disease	disease	O	I_disease
Research	research	O	O
Group	group	O	O
(	(	O	O
UKPDRG	ukpdrg	O	O
)	)	O	O
trial	trial	O	O
found	found	O	O
an	an	O	O
increased	increased	O	O
mortality	mortality	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
Parkinson	parkinson	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
(	(	O	O
PD	pd	O	S_disease
)	)	O	O
randomized	randomized	O	O
to	to	O	O
receive	receive	O	O
10	10	O	O
mg	mg	O	O
selegiline	selegiline	S_chemical	O
per	per	O	O
day	day	O	O
and	and	O	O
L-dopa	l-dopa	O	O
compared	compared	O	O
with	with	O	O
those	those	O	O
taking	taking	O	O
L-dopa	l-dopa	O	O
alone	alone	O	O
.	.	O	O

Recently	recently	O	O
,	,	O	O
we	we	O	O
found	found	O	O
that	that	O	O
therapy	therapy	O	O
with	with	O	O
selegiline	selegiline	S_chemical	O
and	and	O	O
L-dopa	l-dopa	O	O
was	was	O	O
associated	associated	O	O
with	with	O	O
selective	selective	O	O
systolic	systolic	O	O
orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
which	which	O	O
was	was	O	O
abolished	abolished	O	O
by	by	O	O
withdrawal	withdrawal	O	O
of	of	O	O
selegiline	selegiline	S_chemical	O
.	.	O	O

This	this	O	O
unwanted	unwanted	O	O
effect	effect	O	O
on	on	O	O
postural	postural	O	O
blood	blood	O	O
pressure	pressure	O	O
was	was	O	O
not	not	O	O
the	the	O	O
result	result	O	O
of	of	O	O
underlying	underlying	O	O
autonomic	autonomic	O	O
failure	failure	O	O
.	.	O	O

The	the	O	O
aims	aims	O	O
of	of	O	O
this	this	O	O
study	study	O	O
were	were	O	O
to	to	O	O
confirm	confirm	O	O
our	our	O	O
previous	previous	O	O
findings	findings	O	O
in	in	O	O
a	a	O	O
separate	separate	O	O
cohort	cohort	O	O
of	of	O	O
patients	patients	O	O
and	and	O	O
to	to	O	O
determine	determine	O	O
the	the	O	O
time	time	O	O
course	course	O	O
of	of	O	O
the	the	O	O
cardiovascular	cardiovascular	O	O
consequences	consequences	O	O
of	of	O	O
stopping	stopping	O	O
selegiline	selegiline	S_chemical	O
in	in	O	O
the	the	O	O
expectation	expectation	O	O
that	that	O	O
this	this	O	O
might	might	O	O
shed	shed	O	O
light	light	O	O
on	on	O	O
the	the	O	O
mechanisms	mechanisms	O	O
by	by	O	O
which	which	O	O
the	the	O	O
drug	drug	O	O
causes	causes	O	O
orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
.	.	O	O

METHODS	methods	O	O
:	:	O	O
The	the	O	O
cardiovascular	cardiovascular	O	O
responses	responses	O	O
to	to	O	O
standing	standing	O	O
and	and	O	O
head-up	head-up	O	O
tilt	tilt	O	O
were	were	O	O
studied	studied	O	O
repeatedly	repeatedly	O	O
in	in	O	O
PD	pd	O	S_disease
patients	patients	O	O
receiving	receiving	O	O
selegiline	selegiline	S_chemical	O
and	and	O	O
as	as	O	O
the	the	O	O
drug	drug	O	O
was	was	O	O
withdrawn	withdrawn	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Head-up	head-up	O	O
tilt	tilt	O	O
caused	caused	O	O
systolic	systolic	O	O
orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
which	which	O	O
was	was	O	O
marked	marked	O	O
in	in	O	O
six	six	O	O
of	of	O	O
20	20	O	O
PD	pd	O	S_disease
patients	patients	O	O
on	on	O	O
selegiline	selegiline	S_chemical	O
,	,	O	O
one	one	O	O
of	of	O	O
whom	whom	O	O
lost	lost	O	O
consciousness	consciousness	O	O
with	with	O	O
unrecordable	unrecordable	O	O
blood	blood	O	O
pressures	pressures	O	O
.	.	O	O

A	a	O	O
lesser	lesser	O	O
degree	degree	O	O
of	of	O	O
orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
occurred	occurred	O	O
with	with	O	O
standing	standing	O	O
.	.	O	O

Orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
was	was	O	O
ameliorated	ameliorated	O	O
4	4	O	O
days	days	O	O
after	after	O	O
withdrawal	withdrawal	O	O
of	of	O	O
selegiline	selegiline	S_chemical	O
and	and	O	O
totally	totally	O	O
abolished	abolished	O	O
7	7	O	O
days	days	O	O
after	after	O	O
discontinuation	discontinuation	O	O
of	of	O	O
the	the	O	O
drug	drug	O	O
.	.	O	O

Stopping	stopping	O	O
selegiline	selegiline	S_chemical	O
also	also	O	O
significantly	significantly	O	O
reduced	reduced	O	O
the	the	O	O
supine	supine	O	O
systolic	systolic	O	O
and	and	O	O
diastolic	diastolic	O	O
blood	blood	O	O
pressures	pressures	O	O
consistent	consistent	O	O
with	with	O	O
a	a	O	O
previously	previously	O	O
undescribed	undescribed	O	O
supine	supine	O	O
pressor	pressor	O	O
action	action	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
This	this	O	O
study	study	O	O
confirms	confirms	O	O
our	our	O	O
previous	previous	O	O
finding	finding	O	O
that	that	O	O
selegiline	selegiline	S_chemical	O
in	in	O	O
combination	combination	O	O
with	with	O	O
L-dopa	l-dopa	O	O
is	is	O	O
associated	associated	O	O
with	with	O	O
selective	selective	O	O
orthostatic	orthostatic	O	B_disease
hypotension	hypotension	O	S_disease
.	.	O	O

The	the	O	O
possibilities	possibilities	O	O
that	that	O	O
these	these	O	O
cardiovascular	cardiovascular	O	O
findings	findings	O	O
might	might	O	O
be	be	O	O
the	the	O	O
result	result	O	O
of	of	O	O
non-selective	non-selective	O	O
inhibition	inhibition	O	O
of	of	O	O
monoamine	monoamine	B_chemical	O
oxidase	oxidase	I_chemical	O
or	or	O	O
of	of	O	O
amphetamine	amphetamine	S_chemical	O
and	and	O	O
metamphetamine	metamphetamine	O	O
are	are	O	O
discussed	discussed	O	O
.	.	O	O

